UP!
| 2014-12-15 | Downgrade | Cowen and Company | Outperform to Market Perform | |
| 2014-12-03 | Downgrade | Mizuho | Buy to Neutral | $17 |
| 2014-12-03 | Downgrade | Deutsche Bank | Buy to Hold | $17.00 |
| 2014-12-03 | Downgrade | Piper Jaffray | Overweight to Neutral | |
| 2014-12-03 | Downgrade | Deutsche Bank AG | Buy to Hold | $17.00 |
| 2014-12-03 | Downgrade | Piper Jaffray Cos. | Overweight to Neutral | |
| 2014-12-02 | Downgrade | Mizuho | Buy to Neutral | $17.00 |
| 2014-11-04 | Initiated Coverage | Deutsche Bank | Buy | $17.00 |
| 2014-10-29 | Initiated Coverage | Bank of America | Buy | $18.00 |
| 2014-10-29 | Initiated Coverage | Bank of America Corp. | Buy | $18.00 |
| 2014-09-15 | Boost Price Target | Mizuho | $10.00 to $16.00 | |
| 2014-09-15 | Boost Price Target | JMP Securities | Outperform | $10.00 to $15.00 |
| 2014-09-15 | Boost Price Target | Cowen and Company | $9.90 to $12.20 | |
| 2014-09-15 | Upgrade | Jefferies Group | Hold to Buy | $5.00 to $17.00 |
| 2014-09-15 | Upgrade | Piper Jaffray | Positive | $17.00 |
| 2014-06-11 | Boost Price Target | Jefferies Group | Hold | $4.00 to $5.00 |
| 2014-05-09 | Lower Price Target | JMP Securities | $11.00 to $10.00 | |
| 2014-05-02 | Upgrade | Mizuho | Neutral to Buy | $5.00 to $10.00 |
| 2014-05-01 | Boost Price Target | JMP Securities | Outperform | $7.00 to $11.00 |
| 2013-12-11 | Lower Price Target | Summer Street | Buy | $10.00 |
| 2013-12-11 | Downgrade | Mizuho | Buy to Neutral | $11.00 to $5.00 |
| 2013-07-12 | Reiterated | Mizuho | Buy | $10 to $11 |
| 2013-07-08 | Reiterated | Summer Street Research | Buy | $14 to $16 |
| 2013-06-14 | Initiated | Mizuho | Buy | $10 |
| 2011-08-23 | Initiated | JMP Securities | Mkt Outperform | $7 |
| 2010-10-07 | Reiterated | Canaccord Genuity | Buy | $6 to $9 |
| 2010-07-01 | Initiated | Jefferies | Buy | $10 |
| 2010-04-29 | Initiated | Wedbush | Outperform | $9 |
| 2010-04-06 | Initiated | Canaccord Adams | Buy | $6 |
| 2010-01-29 | Initiated | Merriman | Buy | |
| 2007-03-01 | Reiterated | Punk, Ziegel & Co | Sell | $2 to $1.25 |
| 2007-02-27 | Upgrade | Wedbush Morgan | Sell to Hold | $1.50 |
| 2014-12-15 | Downgrade | Cowen and Company | Outperform to Market Perform | |
| 2014-12-03 | Downgrade | Mizuho | Buy to Neutral | $17 |
| 2014-12-03 | Downgrade | Deutsche Bank | Buy to Hold | $17.00 |
| 2014-12-03 | Downgrade | Piper Jaffray | Overweight to Neutral | |
| 2014-12-03 | Downgrade | Deutsche Bank AG | Buy to Hold | $17.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In AVNR 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Katkin Keith President and CEO | 0.53% (914249) | AVNR / RIGL / TKAI / |
| WHEELER CRAIG A | 0.23% (400394) | AVNR / FOLD / MNTA / |
| Podlesak Dennis | 0.20% (336394) | AVNR / RGDO / |
| Mazzo David J | 0.20% (336394) | AVNR / NBS / PSDV / RGDO / |
| Siffert Joao MD SVP, R&D | 0.18% (314192) | AVNR / |
| Whitcup Scott M | 0.18% (306494) | AGN / AVNR / QCOR / |
| PALEKAR ROHAN SVP & Chief Commercial Officer | 0.18% (302806) | AVNR / |
| AUSTIN STEPHEN G | 0.16% (270094) | AVNR / IMMY / |
| OCAMPO CHRISTINE Vice President, Finance | 0.06% (108797) | AVNR / TKAI / |
| Bishop Hans Edgar | 0.05% (93350) | A / AVNR / |
| Nevinny Corinne H | 0.05% (80050) | AVNR / NBIX / |
| Kaye Randall Sr. VP, Chief Medical Officer | 0.04% (65690) | AVNR / |
| Sibold William John SVP & Chief Commercial Officer | 0.01% (20000) | AVNR / |
UM